Neurotherapeutics

• 

  Publication Venue For

  • Oncolytic Viral Therapy for Malignant Glioma and Their Application in Clinical Practice..  19:1818-1831. 2022
  • If Thymectomy Reduces the Risk of Progression of Ocular to Generalized Myasthenia Gravis, Who Should Receive it?.  18:2419-2420. 2021
  • Central Nervous System Targets: Glial Cell Mechanisms in Chronic Pain..  17:846-860. 2020
  • Neuromodulation, Specialized Proresolving Mediators, and Resolution of Pain..  17:886-899. 2020
  • Autoimmune Encephalitis: NMDA Receptor Encephalitis as an Example of Translational Neuroscience..  17:404-413. 2020
  • Therapeutic Development of Apolipoprotein E Mimetics for Acute Brain Injury: Augmenting Endogenous Responses to Reduce Secondary Injury..  17:475-483. 2020
  • Translational Neurocritical Care Research: Advancing Understanding and Developing Therapeutics..  17:389-391. 2020
  • Current Treatment, Emerging Translational Therapies, and New Therapeutic Targets for Autoimmune Myasthenia Gravis..  13:118-131. 2016
  • A Double-Blinded, Randomized, Placebo-Controlled Trial to Evaluate Efficacy, Safety, and Tolerability of Single Doses of Tirasemtiv in Patients with Acetylcholine Receptor-Binding Antibody-Positive Myasthenia Gravis..  12:455-460. 2015
  • Rescue of Methyl-CpG Binding Protein 2 Dysfunction-induced Defects in Newborn Neurons by Pentobarbital..  12:477-490. 2015
  • Inhibition of protein misfolding/aggregation using polyglutamine binding peptide QBP1 as a therapy for the polyglutamine diseases..  10:440-446. 2013
  • Treatment for co-occurring attention deficit/hyperactivity disorder and autism spectrum disorder..  9:518-530. 2012
  • Targeting astrocyte signaling for chronic pain..  7:482-493. 2010
  • Statins in traumatic brain injury..  7:62-73. 2010